Back to top
Top
U.S. flag

An official website of the United States government

Proportion measure

Year CMS eCQM ID Measure Name
2024 CMS130v12 Colorectal Cancer Screening
2025 CMS130v13 Colorectal Cancer Screening
2026 CMS130v14 Colorectal Cancer Screening
2023 CMS131v11 Diabetes: Eye Exam
2024 CMS131v12 Diabetes: Eye Exam
2025 CMS131v13 Diabetes: Eye Exam
2026 CMS131v14 Diabetes: Eye Exam
2023 CMS133v11 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2024 CMS133v12 Cataracts: 20 over 40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2025 CMS133v13 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2026 CMS133v14 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2023 CMS135v11 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 CMS135v12 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 CMS135v13 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2026 CMS135v14 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 CMS136v12 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2024 CMS136v13 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2025 CMS136v14 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2026 CMS136v15 Follow-Up Care for Children Prescribed ADHD Medication
2023 CMS137v11 Initiation and Engagement of Substance Use Disorder Treatment

We want your feedback

For technical questions about eCQMs, please log in to the ONC Project Tracking System, specifically the eCQM Issue Tracker.

eCQI Resource Center Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.